These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28854339)

  • 1. Improving the Safety and Functionality of an Artificial Pancreas System for Use in Younger Children: Input from Parents and Physicians.
    Gildersleeve R; Riggs SL; Cherñavvsky DR; Breton MD; DeBoer MD
    Diabetes Technol Ther; 2017 Nov; 19(11):660-674. PubMed ID: 28854339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
    Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of an Artificial Pancreas System for Young Children with Type 1 Diabetes.
    DeBoer MD; Breton MD; Wakeman C; Schertz EM; Emory EG; Robic JL; Kollar LL; Kovatchev BP; Cherñavvsky DR
    Diabetes Technol Ther; 2017 May; 19(5):293-298. PubMed ID: 28426239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions and expectations of adults with type 1 diabetes for the use of artificial pancreas systems with and without glucagon addition: Results of an online survey.
    Taleb N; Quintal A; Rakheja R; Messier V; Legault L; Racine E; Rabasa-Lhoret R
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):658-665. PubMed ID: 33358714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes.
    Dadlani V; Pinsker JE; Dassau E; Kudva YC
    Curr Diab Rep; 2018 Aug; 18(10):88. PubMed ID: 30159816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A remote monitoring system for artificial pancreas support is safe, reliable, and user friendly.
    Oron T; Farfel A; Muller I; Miller S; Atlas E; Nimri R; Phillip M
    Diabetes Technol Ther; 2014 Nov; 16(11):699-705. PubMed ID: 25211216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiniMed 670G hybrid closed loop artificial pancreas system for the treatment of type 1 diabetes mellitus: overview of its safety and efficacy.
    Saunders A; Messer LH; Forlenza GP
    Expert Rev Med Devices; 2019 Oct; 16(10):845-853. PubMed ID: 31540557
    [No Abstract]   [Full Text] [Related]  

  • 9. Who needs an artificial pancreas? (？).
    Winikoff J; Drexler A
    J Diabetes; 2013 Sep; 5(3):254-7. PubMed ID: 23601378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy options for pediatric diabetes.
    Marcovecchio ML; Chiarelli F
    Curr Opin Pediatr; 2017 Aug; 29(4):481-487. PubMed ID: 28509784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of diabetic ketoacidosis secondary to fulminant type 1 diabetes mellitus using a closed-loop artificial pancreas in a pediatric patient.
    Tamura T; Tadokoro T; Iwata H; Namikawa T; Hanazaki K; Kawano T
    J Artif Organs; 2024 Mar; 27(1):73-76. PubMed ID: 36512306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parent, child, and adolescent lived experience using the insulin-only iLet Bionic Pancreas.
    Howard KR; Garza KP; Feldman M; Weissberg-Benchell J
    J Pediatr Psychol; 2024 Jun; 49(6):413-420. PubMed ID: 38591792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial Pancreas Technology Offers Hope for Childhood Diabetes.
    Schoelwer MJ; DeBoer MD
    Curr Nutr Rep; 2021 Mar; 10(1):47-57. PubMed ID: 33411096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future acceptance of an artificial pancreas in adults with type 1 diabetes.
    van Bon AC; Brouwer TB; von Basum G; Hoekstra JB; DeVries JH
    Diabetes Technol Ther; 2011 Jul; 13(7):731-6. PubMed ID: 21504332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modern clinical management helps reducing the impact of type 1 diabetes in children.
    Scaramuzza AE; Zuccotti GV
    Pharmacol Res; 2015 Aug; 98():16-21. PubMed ID: 25779986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.
    Schmidt S; Boiroux D; Ranjan A; Jørgensen JB; Madsen H; Nørgaard K
    Ther Deliv; 2015; 6(5):609-19. PubMed ID: 26001176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress Testing of an Artificial Pancreas System With Pizza and Exercise Leads to Improvements in the System's Fuzzy Logic Controller.
    Mauseth R; Lord SM; Hirsch IB; Kircher RC; Matheson DP; Greenbaum CJ
    J Diabetes Sci Technol; 2015 Sep; 9(6):1253-9. PubMed ID: 26370244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathway to artificial pancreas systems revisited: moving downstream.
    Kowalski A
    Diabetes Care; 2015 Jun; 38(6):1036-43. PubMed ID: 25998296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The artificial pancreas: current status and future prospects in the management of diabetes.
    Peyser T; Dassau E; Breton M; Skyler JS
    Ann N Y Acad Sci; 2014 Apr; 1311():102-23. PubMed ID: 24725149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of the artificial pancreas in the paediatric population with type 1 diabetes.
    Esposito S; Santi E; Mancini G; Rogari F; Tascini G; Toni G; Argentiero A; Berioli MG
    J Transl Med; 2018 Jun; 16(1):176. PubMed ID: 29954380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.